Quarterly report pursuant to Section 13 or 15(d)

Summary of Stock Options Activity (Details)

v3.22.2.2
Summary of Stock Options Activity (Details) - USD ($)
9 Months Ended
Dec. 09, 2021
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]    
Number of Shares, Beginning Balance   4,176,737
Weighted Average Exercise Price, Beginning Balance   $ 2.59
Weighted Average Grant Date Fair Value, Beginning   $ 2.59
Weighted Average Remaining Contractual Term (Years), Beginning   1 year 3 months 14 days
Aggregate Intrinsic Value, Beginning Balance   $ 14,493,284
Number of Shares, Granted   300,000
Weighted Average Exercise Price, Granted   $ 3.41
Weighted Average Grant Date Fair Value, Granted   $ 3.41
Weighted Average Remaining Contractual Term (Years), Granted   5 years 9 months 18 days
Aggregate Intrinsic Value, Granted   $ 31,000
Number of Shares, Forfeited 11,576
Weighted Average Exercise Price, Granted  
Number of Shares, Forfeited  
Weighted Average Exercise Price, Forfeited  
Weighted Average Grant Date Fair Value, Forfeited  
Number of Shares, Canceled/Expired  
Weighted Average Exercise Price, Canceled/Expired  
Weighted Average Grant Date Fair Value, Canceled/Expired  
Number of Shares, Ending Balance   4,476,737
Weighted Average Exercise Price, Ending Balance $ 2.59 $ 2.64
Weighted Average Grant Date Fair Value, Ending   $ 2.64
Weighted Average Remaining Contractual Term (Years), Ending   10 months 20 days
Aggregate Intrinsic Value, Ending Balance   $ 114,535
Number of Shares, Exercisable   4,376,737
Weighted Average Exercise Price, Exercisable   $ 2.61
Weighted Average Grant Date Fair Value, Exercisable   $ 2.61
Weighted Average Remaining Contractual Term (Years), Exercisable   9 months 7 days
Aggregate Intrinsic Value, Exercisable   $ 114,535